Esophageal cancer: The precursors (Part II)

The epidemiology of esophageal cancer has been considered in part I of this review [1]. Squamous cell carcinoma (SCC), accounts for the majority of cases, which tend to occur in low-resource countries, particularly in certain regions of Asia, where the age-standardized rate (ASR) incidence can be higher than 100/100 000). Adenocarcinoma (ADC) is less frequent and develops from a metaplastic epithelium. The ASR incidence of ADC is higher in Caucasians and in men, but is still low at less than 5 in men and 1 in women; however it is increasing rapidly in the USA, Australia, and northern Europe, and may have a significant impact in the near future.

There is frequent confusion in determining whether the site of ADC is on the esophageal or gastric side of the esophagogastric junction.

The question arises of whether a preneoplastic alteration of the epithelium is the first step in the sequence leading from chronic inflammation to neoplasia.

References

• 1 Lambert R, Hainaut P. Esophageal cancer: Cases and causes (Part I).  Endoscopy. 2007;  39 550-555
• 2 Takubo K, Arai T, Sawabe M. et al . Structures of the normal esophagus and Barrett’s esophagus.  Esophagus. 2003;  1 37-47
• 3 Takubo K, Vieth M, Aryal G. et al . Islands of squamous epithelium and their surrounding mucosa in columnar lined esophagus: a pathognomonic feature of Barrett’s esophagus.  Hum Pathol. 2005;  36 269-274
• 4 Jankowski J A, Harrison R F, Parry I. et al . Barrett’s metaplasia.  Lancet. 2000;  356 2079-2085
• 5 Paris Workshop on Columnar Metaplasia in the Esophagus and the Esophagogastric Junction, Paris, France, December 11 - 12 2004.  Endoscopy. 2005;  37 879-920
• 6 Taniere P, Montesano R, Hainaut P. The natural history of esophageal cancer. In: Shield PG (ed). Cancer risk assessement. London; Taylor and Francis 2005: 601-615
• 7 Taniere P, Martel-Plache G, Saurin J C. et al . TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe.  Br J Cancer. 2001;  85 721-726
• 8 Sepehr A, Taniere P, Martel-Planche G. et al . Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.  Oncogene. 2001;  20 7368-7374
• 9 Mandard A M, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus.  Mutat Res. 2000;  462 335-342
• 10 Mandard A M, Marnav J, Lebeau C. et al . Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesophagus, with special reference to uninvolved mucosa.  J Pathol. 1997;  18 153-157
• 11 Wang L D, Liu B, Zgen S. Analysis of p53 mutational spectra of esophageal squamous cell carcinomas from Linzhou, comparison with esophageal and other cancers from other areas [in Chinese].  Zhonghua Liu Xing Bing Xue Za Zhi. 2003;  24 202-205
• 12 Levrero M, De Laurenzi V, Costanzo A. et al . The p53 /p53/p63eightsp;p63/p73 family of transcription factors: overlapping and distinct functions.  J Cell Sci. 2000;  113 1661-1670
• 13 Daniely Y, Yao G, Dixon D. et al . Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium.  Am J Physiol Cell Physiol. 2004;  287 C171-C181
• 14 Morita M, Uramoto H, Ono K. et al . Expression of deltaNp63 in squamous cell carcinoma of the esophagus.  Anticancer Res. 2005;  25 3533-3539
• 15 Hall P A, Woodman A C, Campbell S J. et al . Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett’s oesophagus: correlation with morphology and p53 protein.  Gut. 2001;  49 618-623
• 16 Taniere P, Borghi-Scoazec G, Saurin J C. et al . Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.  Am J Surg Pathol. 2002;  26 1213-1221
• 17 Shimizu D, Vallbohmer D, Kuramochi H. et al . Increasing cyclooxygenase-2 (cox-2) gene expression in the progression of Barrett’s esophagus to adenocarcinoma correlates with that of Bcl-2.  Int J Cancer. 2006;  119 765-770
• 18 Inoue H, Rey J F, Lightdale C. Lugol chromoendoscopy for esophageal squamous cell cancer.  Endoscopy. 2001;  33 75-79
• 19 Lundell L R, Dent J, Bennet J R. et al . Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification.  Gut. 1999;  45 172-180
• 20 Labenz J, Jaspersen D, Kulig M. et al . Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative.  Am J Gastroenterol. 2004;  99 1652-1656
• 21 Noori P, Hou S M. Mutational spectrum induced by acetaldehyde in the HPRT gene of human T lymphocytes resembles that in the p53 gene of esophageal cancers.  Carcinogenesis. 2001;  22 1825-1830
• 22 Jacob J H, Riviere A, Mandard A M. et al . Prevalence survey of precancerous lesions of the oesophagus in a high-risk population for oesophageal cancer in France.  Eur J Cancer Prev. 1993;  2 53-59
• 23 Zhengzhou University International Symposium on Esophageal Cancer. 2005 August 27 - 30, Zhengzhou, China [unpublished data]
• 24 Wahrendorf J, Chang-Claude J C, Liang Q S. et al . Precursor lesions of oesophageal cancer in young people in a high-risk population in China.  Lancet. 1989;  2 1239-1241
• 25 Chang-Claude J C, Wahrendorf J, Liang Q S. et al . An epidemiological study of precursor lesions of esophageal cancer among young persons in a high-risk population in Huixian, China.  Cancer Res. 1990;  50 2268-2274
• 26 Dawsey S M, Lewin K J, Wang G Q. et al . Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China.  Cancer. 1994;  74 1686-1692
• 27 Wang G Q, Abnet C C, Shen Q. et al . Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population.  Gut. 2005;  54 187-92
• 28 Wei W Q, Abnet C C, Lu N. et al . Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China.  Gut. 2005;  54 759-763
• 29 Lu X J, Chen Z F, Guo C L. et al . Endoscopic survey of esophageal cancer in a high-risk area of China.  World J Gastroenterol. 2004;  10 2931-2935
• 30 Qiu S L, Yang G R. Precursor lesions of esophageal cancer in high risk populations in Henan province, China.  Cancer. 1988;  62 551-557
• 31 Yang G R, Qiu S L. Endoscopic surveys in high-risk and low-risk populations for esophageal cancer in China with special reference to precursors of esophageal cancer.  Endoscopy. 1987;  19 91-95
• 32 Munoz N, Crespi M, Grassi A. et al . Precursor lesions of oesophageal cancer in high-risk populations in Iran and China.  Lancet. 1982;  1 876-879
• 33 Crespi M, Munoz N, Grassi A. et al . Precursor lesions of oesophageal cancer in a low-risk population in China: comparison with high-risk populations.  Int J Cancer. 1984;  34 599-602
• 34 Pourshams A, Saadatian-Elahi M, Nouraie M. et al . Golestan cohort study of oesophageal cancer: feasibility and first results.  Br J Cancer. 2005;  92 176-181
• 35 Turkdogan M K, Akman N, Tuncer I. Epidemiological aspects of endemic upper gastrointestinal cancers in eastern Turkey.  Hepatogastroenterology. 2005;  52 496-500
• 36 Jaskiewicz K, Venter F S, Marasas W F. Cytopathology of the esophagus in Transkei.  J Natl Cancer Inst. 1987;  79 961-967
• 37 Liu C G, Zhang K, Jiang Y. et al . Modulation of gene expression in precancerous rat esophagus by dietary zinc deficit and replenishment.  Cancer Res. 2005;  65 7790-7799
• 38 Kamangar F, Strickland P T, Poursham A. et al . High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran.  Anticancer Res. 2005;  25 425-428
• 39 Sepehr A, Kamangar F, Fahimi S. et al . Poor oral health as a risk factor for esophageal squamous dysplasia in northeastern Iran.  Anticancer Res. 2005;  25 543-546
• 40 Si H X, Tsao S W, Poon C S. et al . Viral load of HPV in esophageal squamous cell carcinoma.  Int J Cancer. 2003;  103 496-500
• 41 Crespi M, Munoz N, Grassi A. Oesophageal lesions in northern Iran: a premalignant condition?.  Lancet. 1979;  2 217-221
• 42 Endo T, Awakawa T, Takahashi H. et al . Classification of Barrett’s epithelium by magnifying endoscopy.  Gastrointest Endosc. 2002;  55 641-647
• 43 Ronkainen J, Aro P, Storzkrubb T. et al . Prevalence of Barrett’s esophagus in the general population: an endoscopic study.  Gastroenterology. 2005;  129 1825-1831
• 44 Spechler S J. Barrett’s esophagus: an overrated cancer risk factor.  Gastroenterology. 2000;  119 587-589
• 45 Reid B J, Blount P L, Rabinovitch P S. Biomarkers in Barrett’s esophagus.  Gastrointest Endosc Clin N Am. 2003;  13 369-397
• 46 Burgh van der A, Dees J, Hop W CJ. et al . Oesophageal cancer is an uncommon cause of death in patients with Barrett’s esophagus.  Gut. 1996;  39 5-8